header-logo header-logo

10 October 2013 / Sarah Moore
Issue: 7579 / Categories: Opinion
printer mail-detail

Time for a litigation supplement?

130896003

Sarah Moore exposes some regulatory deficiencies in the world of vitamins & supplements

In the UK, the “nutritional supplement” and vitamin industry is big business—currently worth around £400m a year. One factor facilitating this growth is a regulatory environment that allows companies to promote their products in flagrant breach of labelling and advertising rules, with little risk of significant penalty or large scale consumer litigation.

As a result, the UK consumer is left exposed to the misleading claims of some manufacturers who promote their “health” products with labelling fictions that have little to do with the product inside the packaging. On the whole, the risk for consumers of vitamins and supplements is not one of personal injury per se, but rather that they purchase expensive products on the basis of fraudulent labelling claims. Within this context it is vital that manufacturers are compelled to either substantiate their products’ claims to medical efficacy, or remove them: under the current regulatory system in the UK this is not happening.

At the end of August, the consumer group Which? published “Health Products You Don’t Need”,

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Jurit LLP—Caroline Williams

Jurit LLP—Caroline Williams

Private wealth and tax team welcomes cross-border specialist as consultant

Freeths—Michelle Kirkland Elias

Freeths—Michelle Kirkland Elias

International hospitality and leisure specialist joins corporate team as partner

Flint Bishop—Deborah Niven

Flint Bishop—Deborah Niven

Firm appoints head of intellectual property to drive northern growth

NEWS
Talk of a reserved ‘Welsh seat’ on the Supreme Court is misplaced. In NLJ this week, Professor Graham Zellick KC explains that the Constitutional Reform Act treats ‘England and Wales’ as one jurisdiction, with no statutory Welsh slot
The government’s plan to curb jury trials has sparked ‘jury furore’. Writing in NLJ this week, David Locke, partner at Hill Dickinson, says the rationale is ‘grossly inadequate’
A year after the $1.5bn Bybit heist, crypto fraud is booming—but so is recovery. Writing in NLJ this week, Neil Holloway, founder and CEO of M2 Recovery, warns that scams hit at least $14bn in 2025, fuelled by ‘pig butchering’ cons and AI deepfakes
After Woodcock confirmed no general duty to warn, debate turns to the criminal law. Writing in NLJ this week, Charles Davey of The Barrister Group urges revival of misprision or a modern equivalent
Family courts are tightening control of expert evidence. Writing in NLJ this week, Dr Chris Pamplin says there is ‘no automatic right’ to call experts; attendance must be ‘necessary in the interests of justice’ under FPR Pt 25
back-to-top-scroll